Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsInnovative Cellular Therapeutics, Inc. announced that the first patient has been enrolled in its Phase I trial of GCC19CART for relapsed/refractory metastatic colorectal cancer.
[Innovative Cellular Therapeutics, Inc.]
Home Newsletters Cell Therapy News Innovative Cellular Therapeutics (ICT) Announces First Patient Enrolled for the Company’s Phase...
